July 19 (Reuters) - The president of Stanford University, one of the most prestigious U.S. schools, announced plans on Wednesday to resign his post after an independent review ordered by its board of trustees found flaws in his research as a neuroscientist. Those allegations were in connection with Alzheimer's disease research carried out when Tessier-Lavigne was the executive vice president of research drug discovery at the U.S. biotechnology company Genentech Inc. But the review of 12 research papers dating over two decades found that when concerns about the research were raised, "Tessier-Lavigne failed to decisively and forthrightly correct mistakes in the scientific record." As a result of the review, Tessier-Lavigne said he was going to retract three papers and correct another two. The board of trustees named Richard Saller, a professor in Stanford's Department of Classics, as interim president beginning Sept. 1.

---

Persons: Marc Tessier, Lavigne, Tessier, " Tessier, Richard Saller, Brad Brooks, Will Dunham, Donna Bryson Organizations: Stanford University, Stanford, University, Genentech Inc, Stanford's Department of Classics, Thomson Locations: U.S, Palo Alto , California, Lubbock , Texas